ライフサイエンスコーパス: lysergic acid diethylamide

1 le compared with the prototypic hallucinogen lysergic acid diethylamide.

2 telet membrane 5-HT2A receptors by using [3H]lysergic acid diethylamide.

3 etanserin (100 nM), mesulergine (100 nM) and lysergic acid diethylamide (1 microM) significantly redu

4 Tissue receptor autoradiography with 3H-lysergic acid diethylamide (3H-LSD), 3H-8-hydroxy-2-[di-

5 inding affinities were determined using [3H]-lysergic acid diethylamide ([3H]-LSD) binding to cell me

6 tetrahydrocannabinol, and psychedelics like lysergic acid diethylamide all directly bind to GPCRs to

7 ted by 33% of the sample, most commonly LSD (lysergic acid diethylamide), amphetamines, Ecstasy (meth

8 pressed high affinity binding sites for 125I-lysergic acid diethylamide and [3H]mesulergine.

9 Psychedelic drugs, including lysergic acid diethylamide and other agonists of the ser

10 Classic hallucinogens such as lysergic acid diethylamide are thought to elicit their p

11 Additionally, illness or lysergic acid diethylamide exposure during pregnancy pro

12 ed the PLC-IP pathway, whereas others (e.g., lysergic acid diethylamide) favored the PLA2-AA pathway.

13 emical studies showing that the hallucinogen lysergic acid diethylamide, its precursor ergotamine (ER

14 thylenedioxymethamphetamine (known as MDMA), lysergic acid diethylamide (known as LSD), psilocybin, o

15 Healthy male volunteers were randomized into lysergic acid diethylamide (LSD) (n = 40) and placebo (n

16 Lysergic acid diethylamide (LSD) and 3,4-Methylenedioxym

17 ly receptors represent essential targets for lysergic acid diethylamide (LSD) and all other psychedel

18 Research on psychedelics such as lysergic acid diethylamide (LSD) and dissociative drugs

19 reported psychedelic compounds - psilocybin, lysergic acid diethylamide (LSD) and ketamine.

20 uestions were asked about: use of ayahuasca, lysergic acid diethylamide (LSD) and magic mushrooms; de

21 d classical psychedelics such as psilocybin, lysergic acid diethylamide (LSD) and N,N-dimethyltryptam

22 Psychedelic drugs, including lysergic acid diethylamide (LSD) and other agonists of t

23 Psychedelic substances such as lysergic acid diethylamide (LSD) and psilocybin show pot

24 Psychedelics including lysergic acid diethylamide (LSD) and psilocybin temporar

25 ound that neural and experiential effects of lysergic acid diethylamide (LSD) are attributable to ago

26 silocybin, N,N'-dimethyltryptamine (DMT) and lysergic acid diethylamide (LSD) are undergoing a renais

27 ng method for quantitation of (3)H-labeled d-lysergic acid diethylamide (LSD) binding to recombinant

28 l studies have reported that the psychedelic lysergic acid diethylamide (LSD) enhances empathy and so

29 Psilocybin and lysergic acid diethylamide (LSD) experiences can range f

30 sic psychedelic drugs such as psilocybin and lysergic acid diethylamide (LSD) have recaptured the ima

31 40 years, there is renewed interest in using lysergic acid diethylamide (LSD) in clinical psychiatric

32 Lysergic acid diethylamide (LSD) is a non-selective sero

33 Lysergic acid diethylamide (LSD) is a prototypical hallu

34 Lysergic acid diethylamide (LSD) is the prototypical psy

35 ies have started to elucidate the effects of lysergic acid diethylamide (LSD) on the human brain but

36 -)-2,5-dimethoxy-4-iodoamphetamine (DOI) and lysergic acid diethylamide (LSD) stimulated a head-twitc

37 ere, we investigate the neural mechanisms of lysergic acid diethylamide (LSD) using regression dynami

38 nthesis of (+)-JRT, a structural analogue of lysergic acid diethylamide (LSD) with lower hallucinogen

39 linical trials investigating the efficacy of lysergic acid diethylamide (LSD), 3,4-methylenedioxymeth

40 Lysergic acid diethylamide (LSD), a semisynthetic ergoli

41 Using the ergoline lysergic acid diethylamide (LSD), and a series of substi

42 d CTSC regions after acute administration of lysergic acid diethylamide (LSD), and after pretreatment

43 Classical psychedelics such as psilocybin, lysergic acid diethylamide (LSD), and N,N-dimethyltrypta

44 During altered states, including after lysergic acid diethylamide (LSD), complexity is increase

45 Microdosing psychedelics, including lysergic acid diethylamide (LSD), has gained attention f

46 However, other 5-HT2A receptor ligands like lysergic acid diethylamide (LSD), in which the amine nit

47 ggest that repeated use of very low doses of lysergic acid diethylamide (LSD), known as microdosing,

48 nogens, including mescaline, psilocybin, and lysergic acid diethylamide (LSD), profoundly affect perc

49 The classical psychedelics (+)-lysergic acid diethylamide (LSD), psilocybin, and mescal

50 Hallucinogens like lysergic acid diethylamide (LSD), psilocybin, and substi

51 ring drugs: propofol, sevoflurane, ketamine, lysergic acid diethylamide (LSD), psilocybin, N,N-Dimeth

52 elated networks underlie the peak effects of lysergic acid diethylamide (LSD), we applied dynamic cau

53 onergic psychedelics, such as psilocybin and lysergic acid diethylamide (LSD), which have a key locus

54 ed to investigate the efficacy and safety of lysergic acid diethylamide (LSD)-assisted therapy in pat

55 a generally more positive view of the use of lysergic acid diethylamide (LSD).

56 b and 6e-f, betaarr2 preferring, relative to lysergic acid diethylamide (LSD).

57 condition (placebo) and during ingestion of lysergic acid diethylamide (LSD).

58 The hallucinogen lysergic acid diethylamide (LSD; 0.1 mg/kg, i.p.) caused

59 viewed journals, reporting on "psilocybin," "lysergic acid diethylamide," "LSD," "ayahuasca," "3,4-me

60 ds of recent other drug use (eg, cocaine and lysergic acid diethylamide; odds ratio [OR], 1.73; 95% C

61 The hallucinogens studied [d-lysergic acid diethylamide, psilocin, bufotenin, and (+/

62 hallucinogenic drugs, such as psilocybin and lysergic acid diethylamide, require the 2AR and resemble

63 ne (selective for the 5-HT2C receptor) and d-lysergic acid diethylamide (selective for the 5-HT2A rec

64 significantly higher risk of dependence than lysergic acid diethylamide users.